A Clearinghouse for Information about Blood Clots (DVT/)PE) and Clotting Disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center

Category: Special situations

  • Skyla – A New IUD, Suitable for Women at Risk for DVT and PE

    Dr. Stephan Moll writes… Skyla® is a new IUD (intrauterine device) contraceptive, approved in February 2013 by the FDA.  Skyla® is like a small version of the Mirena® IUD.  It has the following features:

  • Klippel-Trenaunay Syndrome, DVT and PE

    Stephan Moll, MD writes…  Klippel-Trenaunay Syndrome (KTS) is a rare congenital disorder of capillary, venous and lymphatic malformations and a localized disturbed growth of bone and/or soft tissue (see photographs)[ref 1].  Patients with KTS are at significantly increased risk for DVT, PE and superficial thrombophlebitis.  KTS affects only one side of the body, typically the leg or the…

  • Recovery After a DVT or PE

    Stephan Moll, MD writes…  A discussion for patients of questions commonly asked after a DVT are discussed here, in Clot Connect’s patient blog, such as: How quickly can I expect improvement? How active can I be after a DVT or PE? When can I go back to doing sports? When is it safe to fly again…

  • Yasmin, Yaz and Other Drospirenone Contraceptives: Risk for VTE

    It has long been known that estrogen-containing birth control preparations (pill, patch, ring) increase the risk for DVT and PE (venous thromboembolism = VTE).  This risk is partially due to the estrogen.  However, part of the risk is also due to the type of progestin in these preparations.

  • Yasmin, Yaz, Angeliq and Risk for Blood Clots

    Birth control pills, patches and rings typically contain an estrogen and a progestin component.  It has long been known that estrogen-containing birth control preparations (pill, patch, ring) increase the risk for blood clots (DVT, PE).  This risk is partially due to the estrogen.  However, part of the risk for clots is also due to the…

  • Pregnancy and Blood Clots: Prevention, Diagnosis, Treatment

    A new guideline about the prevention, diagnosis, and treatment of DVT and PE associated with pregnancy was published today by ACOG (American College of Obstetricians and Gynecologists) in its respected series of Practice Bulletins.  The bulletin also takes detailed reference to prevention of blood clots in pregnant women with thrombophilia.

  • Pregnancy and Venous Thromboembolism: Prevention, Diagnosis, Treatment

    A new guideline about the prevention, diagnosis, and treatment of DVT and PE associated with pregnancy was published today by ACOG (American College of Obstetricians and Gynecologists) in its respected series of Practice Bulletins.  The bulletin includes detailed reference to thromboprophylaxis in pregnant women with thrombophilia.

  • Postpartum – Safe Contraceptive Methods

    The CDC today published recommendations on use of contraceptive methods for non-breast feeding women in the post-partum period (full text is here).  The key recommendations are as follows: